WallStSmart

DocGo Inc (DCGO)vsDaVita HealthCare Partners Inc (DVA)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

DaVita HealthCare Partners Inc generates 4654% more annual revenue ($14.01B vs $294.72M). DVA leads profitability with a 6.0% profit margin vs -65.3%. DVA earns a higher WallStSmart Score of 70/100 (B).

DCGO

Hold

36

out of 100

Grade: F

Growth: 3.3Profit: 2.0Value: 6.7Quality: 5.5
Piotroski: 3/9Altman Z: -1.24

DVA

Strong Buy

70

out of 100

Grade: B

Growth: 7.3Profit: 7.0Value: 7.3Quality: 5.5
Piotroski: 3/9Altman Z: 1.22
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DCGOUndervalued (+63.6%)

Margin of Safety

+63.6%

Fair Value

$2.00

Current Price

$0.34

$1.66 discount

UndervaluedFair: $2.00Overvalued
DVAOvervalued (-12.9%)

Margin of Safety

-12.9%

Fair Value

$127.80

Current Price

$178.47

$50.67 premium

UndervaluedFair: $127.80Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DCGO2 strengths · Avg: 9.5/10
Price/BookValuation
0.3x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.229/10

Conservative balance sheet, low leverage

DVA5 strengths · Avg: 9.6/10
PEG RatioValuation
0.4510/10

Growing faster than its price suggests

Return on EquityProfitability
81.0%10/10

Every $100 of equity generates 81 in profit

EPS GrowthGrowth
55.8%10/10

Earnings expanding 55.8% YoY

Debt/EquityHealth
-14.0910/10

Conservative balance sheet, low leverage

P/E RatioValuation
15.6x8/10

Attractively priced relative to earnings

Areas to Watch

DCGO4 concerns · Avg: 2.5/10
Market CapQuality
$34.08M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-141.9%2/10

ROE of -141.9% — below average capital efficiency

Revenue GrowthGrowth
-8.7%2/10

Revenue declined 8.7%

DVA3 concerns · Avg: 2.7/10
Profit MarginProfitability
6.0%3/10

6.0% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : DCGO

The strongest argument for DCGO centers on Price/Book, Debt/Equity.

Bull Case : DVA

The strongest argument for DVA centers on PEG Ratio, Return on Equity, EPS Growth. PEG of 0.45 suggests the stock is reasonably priced for its growth.

Bear Case : DCGO

The primary concerns for DCGO are Market Cap, Piotroski F-Score, Return on Equity.

Bear Case : DVA

The primary concerns for DVA are Profit Margin, Piotroski F-Score, Altman Z-Score.

Key Dynamics to Monitor

DCGO profiles as a turnaround stock while DVA is a value play — different risk/reward profiles.

DCGO carries more volatility with a beta of 0.94 — expect wider price swings.

DVA is growing revenue faster at 5.2% — sustainability is the question.

DVA generates stronger free cash flow (320M), providing more financial flexibility.

Bottom Line

DVA scores higher overall (70/100 vs 36/100). DCGO offers better value entry with a 63.6% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

DocGo Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

DocGo Inc. is a leading mobile healthcare service provider focused on enhancing patient accessibility and optimizing healthcare delivery through its cutting-edge logistics and telehealth solutions. The company specializes in urgent care, diagnostic testing, and health screenings, effectively addressing key healthcare challenges across diverse environments and significantly improving patient experiences. With a strong commitment to innovation and expanding access to healthcare, DocGo is well-positioned in the dynamic healthtech sector, making it an attractive investment opportunity for institutional investors interested in sustainable growth and impactful social contributions.

Visit Website →

DaVita HealthCare Partners Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

DaVita Inc. provides kidney dialysis services through a network of outpatient dialysis centers in the United States.

Want to dig deeper into these stocks?